about
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tra...
Read More
1.24
0.04
(3.33%)
72,662
XNAS Volume
XNAS 31 Jul, 2025 11:01 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
RenovoRx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..